Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 2/20 | 0.51 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.50 |
| ▸ | METTL14 | Q9HCE5 | 1/20 | 0.50 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14568724 | 0.90 | SLC29A1 (0.49) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL14568617 | 0.90 | SLC29A1 (0.49) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL13005628 | 0.87 | ADK (0.64) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL10160817 | 0.87 | ADK (0.64) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL1797344 | 0.87 | ADK (0.64) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL10131093 | 0.87 | ADK (0.64) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL14440645 | 0.87 | ADK (0.64) | ADKMETTL3 | |
| SCHEMBL14440630 | 0.86 | ADK (0.63) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL14440901 | 0.86 | ADK (0.63) | ADKMETTL3METTL14SLC29A1 | |
| SCHEMBL23982307 | 0.85 | PRMT5 (0.47) | ADKSLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | NSUN2, NSUN3, HAVCR2 | ADK 359/4885METTL3 80/4885METTL14 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.